Formosa Optical Technology Co Ltd
Formosa Optical Technology Co.,Ltd. provides eyecare products in Taiwan. The company provides optical glasses, sunglasses, contact transparent lenses, and color contact lenses. It offers optometry equipment. The company was founded in 1976 and is based in New Taipei City, Taiwan.
Formosa Optical Technology Co Ltd (5312) - Net Assets
Latest net assets as of September 2025: NT$3.48 Billion TWD
Based on the latest financial reports, Formosa Optical Technology Co Ltd (5312) has net assets worth NT$3.48 Billion TWD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$8.80 Billion) and total liabilities (NT$5.32 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$3.48 Billion |
| % of Total Assets | 39.57% |
| Annual Growth Rate | 9.76% |
| 5-Year Change | 33.46% |
| 10-Year Change | 53.72% |
| Growth Volatility | 9.24 |
Formosa Optical Technology Co Ltd - Net Assets Trend (2002–2024)
This chart illustrates how Formosa Optical Technology Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Formosa Optical Technology Co Ltd (2002–2024)
The table below shows the annual net assets of Formosa Optical Technology Co Ltd from 2002 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | NT$3.48 Billion | +17.38% |
| 2023-12-31 | NT$2.96 Billion | +14.03% |
| 2022-12-31 | NT$2.60 Billion | -1.89% |
| 2021-12-31 | NT$2.65 Billion | +1.63% |
| 2020-12-31 | NT$2.61 Billion | +2.80% |
| 2019-12-31 | NT$2.54 Billion | +6.34% |
| 2018-12-31 | NT$2.38 Billion | +2.58% |
| 2017-12-31 | NT$2.32 Billion | +0.98% |
| 2016-12-31 | NT$2.30 Billion | +1.72% |
| 2015-12-31 | NT$2.26 Billion | +5.98% |
| 2014-12-31 | NT$2.14 Billion | +8.10% |
| 2013-12-31 | NT$1.98 Billion | +20.77% |
| 2012-12-31 | NT$1.64 Billion | +33.45% |
| 2011-12-31 | NT$1.23 Billion | +19.05% |
| 2010-12-31 | NT$1.03 Billion | +10.08% |
| 2009-12-31 | NT$935.17 Million | +1.38% |
| 2008-12-31 | NT$922.41 Million | +9.23% |
| 2007-12-31 | NT$844.47 Million | -2.08% |
| 2006-12-31 | NT$862.43 Million | +14.45% |
| 2005-12-31 | NT$753.57 Million | +16.21% |
| 2004-12-31 | NT$648.48 Million | +14.88% |
| 2003-12-31 | NT$564.46 Million | +26.03% |
| 2002-12-31 | NT$447.89 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Formosa Optical Technology Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 4144.7% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | NT$1.65 Billion | 47.57% |
| Other Components | NT$1.82 Billion | 52.43% |
| Total Equity | NT$3.47 Billion | 100.00% |
Formosa Optical Technology Co Ltd Competitors by Market Cap
The table below lists competitors of Formosa Optical Technology Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Everest Textile Co Ltd
TW:1460
|
$88.63 Million |
|
Excellence Optoelectronic Inc
TW:6288
|
$88.63 Million |
|
ReneSola Ltd
F:VQKB
|
$88.68 Million |
|
Expert.ai S.p.A
OTCGREY:EXSPF
|
$88.73 Million |
|
Park City Group Inc
F:PJ4A
|
$88.56 Million |
|
THONBURI HEALTHCARE GRO-NVDR
BK:THG-R
|
$88.55 Million |
|
Fenix Resources Limited
F:4ER
|
$88.47 Million |
|
Openedges Tech Inc
KQ:394280
|
$88.46 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Formosa Optical Technology Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,957,691,000 to 3,472,910,000, a change of 515,219,000 (17.4%).
- Net income of 494,812,000 contributed positively to equity growth.
- Dividend payments of 360,359,000 reduced retained earnings.
- Other factors increased equity by 380,766,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$494.81 Million | +14.25% |
| Dividends Paid | NT$360.36 Million | -10.38% |
| Other Changes | NT$380.77 Million | +10.96% |
| Total Change | NT$- | 17.42% |
Book Value vs Market Value Analysis
This analysis compares Formosa Optical Technology Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.69x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 2.55x to 1.69x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | NT$38.46 | NT$98.00 | x |
| 2018-12-31 | NT$39.52 | NT$98.00 | x |
| 2019-12-31 | NT$42.07 | NT$98.00 | x |
| 2020-12-31 | NT$43.15 | NT$98.00 | x |
| 2021-12-31 | NT$43.94 | NT$98.00 | x |
| 2022-12-31 | NT$43.08 | NT$98.00 | x |
| 2023-12-31 | NT$49.10 | NT$98.00 | x |
| 2024-12-31 | NT$57.82 | NT$98.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Formosa Optical Technology Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 14.25%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 12.46%
- • Asset Turnover: 0.50x
- • Equity Multiplier: 2.30x
- Recent ROE (14.25%) is below the historical average (15.21%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 9.57% | 4.16% | 1.33x | 1.73x | NT$-1.93 Million |
| 2003 | 12.69% | 6.15% | 1.33x | 1.55x | NT$15.20 Million |
| 2004 | 16.70% | 7.77% | 1.39x | 1.55x | NT$43.47 Million |
| 2005 | 18.95% | 9.38% | 1.25x | 1.61x | NT$67.44 Million |
| 2006 | 20.25% | 10.74% | 1.13x | 1.67x | NT$88.38 Million |
| 2007 | 16.02% | 7.79% | 1.29x | 1.59x | NT$50.86 Million |
| 2008 | 15.48% | 7.92% | 1.24x | 1.58x | NT$50.55 Million |
| 2009 | 16.96% | 8.95% | 1.15x | 1.64x | NT$65.07 Million |
| 2010 | 22.49% | 12.22% | 1.08x | 1.70x | NT$128.11 Million |
| 2011 | 18.37% | 11.15% | 1.03x | 1.61x | NT$102.58 Million |
| 2012 | 18.85% | 14.29% | 0.88x | 1.50x | NT$144.79 Million |
| 2013 | 18.07% | 16.07% | 0.76x | 1.47x | NT$159.44 Million |
| 2014 | 16.51% | 14.69% | 0.75x | 1.50x | NT$138.98 Million |
| 2015 | 16.50% | 14.69% | 0.61x | 1.83x | NT$147.02 Million |
| 2016 | 15.72% | 13.35% | 0.63x | 1.86x | NT$130.75 Million |
| 2017 | 13.17% | 10.66% | 0.67x | 1.84x | NT$73.13 Million |
| 2018 | 10.68% | 8.27% | 0.69x | 1.87x | NT$16.18 Million |
| 2019 | 15.00% | 11.79% | 0.60x | 2.11x | NT$126.39 Million |
| 2020 | 11.86% | 10.07% | 0.54x | 2.18x | NT$48.26 Million |
| 2021 | 10.95% | 9.95% | 0.51x | 2.16x | NT$25.16 Million |
| 2022 | 6.56% | 5.16% | 0.52x | 2.45x | NT$-89.11 Million |
| 2023 | 14.13% | 10.82% | 0.54x | 2.41x | NT$122.17 Million |
| 2024 | 14.25% | 12.46% | 0.50x | 2.30x | NT$147.52 Million |
Industry Comparison
This section compares Formosa Optical Technology Co Ltd's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,796,147,300
- Average return on equity (ROE) among peers: 10.94%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Formosa Optical Technology Co Ltd (5312) | NT$3.48 Billion | 9.57% | 1.53x | $88.60 Million |
| St.Shine Optical Co Ltd (1565) | $5.39 Billion | 29.48% | 0.60x | $147.19 Million |
| Nang Kuang Pharmaceutical Co Ltd (1752) | $2.19 Billion | 9.94% | 0.50x | $46.91 Million |
| Maxigen Biotech Inc (1783) | $1.14 Billion | 7.68% | 0.11x | $53.63 Million |
| SciVision Biotech Inc (1786) | $1.02 Billion | -2.16% | 0.07x | $107.95 Million |
| Bioteque (4107) | $1.88 Billion | 15.46% | 0.25x | $198.92 Million |
| Chi Sheng Chemical (4111) | $1.22 Billion | 12.60% | 0.47x | $41.85 Million |
| Sunder Biomedical Tech. Co., Ltd. (4115) | $790.45 Million | 1.68% | 0.80x | $2.11K |
| BenQ Medical Technology (4116) | $1.10 Billion | 2.62% | 0.78x | $25.45 Million |
| Pacific Hospital Supply Co Ltd (4126) | $2.26 Billion | 10.49% | 0.61x | $128.74 Million |
| Unicon Optical Co., Ltd. (4150) | $963.23 Million | 21.57% | 0.59x | $22.68 Million |